Dissertations / Theses on the topic 'Anti-inflammatory molecules'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 dissertations / theses for your research on the topic 'Anti-inflammatory molecules.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse dissertations / theses on a wide variety of disciplines and organise your bibliography correctly.
Coste, Emmanuel. "Development of small molecules as anti-inflammatory and anti-resorptive drugs." Thesis, University of Edinburgh, 2011. http://hdl.handle.net/1842/9941.
Full textBattu, Ganga Rao. "Anti-inflammatory and phytochemical studies of a Kenyan traditional medicinal plant, Commiphora kua." Thesis, University of Strathclyde, 2001. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.366837.
Full textPrins, Louis Hendrik Albertus. "Polycyclic cage compounds as carrier molecules for neuroprotective non-steroidal anti-inflammatory drugs / Louis H.A. Prins." Thesis, North-West University, 2007. http://hdl.handle.net/10394/1479.
Full textEduardo, Da Silva Acarilia. "Nanotechnological delivery systems for the oral administration of active molecules : Polymeric microparticles and microemulsions applied to anti-inflammatory and anti-infectious drugs." Phd thesis, Université Paris Sud - Paris XI, 2013. http://tel.archives-ouvertes.fr/tel-00856598.
Full textSilva, Acarilia Eduardo da. "Nanotechnological delivery systems for the oral administration of active molecules: Polymeric microparticles and microemulsions applied to anti-inflammatory and anti-infectious drugs." Universidade Federal do Rio Grande do Norte, 2013. http://repositorio.ufrn.br:8080/jspui/handle/123456789/13309.
Full textConselho Nacional de Desenvolvimento Cient?fico e Tecnol?gico
This thesis was devoted to the development of innovative oral delivery systems for two different molecules. In the first part, microparticles (MPs) based on xylan and Eudragit? S- 100 were produced and used to encapsulate 5-aminosalicylic acid for colon delivery. Xylan was extracted from corn cobs and characterized in terms of its physicochemical, rheological and toxicological properties. The polymeric MPs were prepared by interfacial cross-linking polymerization and spray-drying and characterized for their morphology, mean size and distribution, thermal stability, crystallinity, entrapment efficiency and in vitro drug release. MPs with suitable physical characteristics and satisfactory yields were prepared by both methods, although the spray-dried systems showed higher thermal stability. In general, spraydried MPs would be preferable systems due to their thermal stability and absence of toxic agents used in their preparation. However, drug loading and release need to be optimized. In the second part of this thesis, oil-in-water microemulsions (O/W MEs) based on mediumchain triglycerides were formulated as drug carriers and solubility enhancers for amphotericin B (AmB). Phase diagrams were constructed using surfactant blends with hydrophiliclipophilic balance values between 9.7 and 14.4. The drug-free and drug-loaded MEs presented spherical non-aggregated droplets around 80 and 120 nm, respectively, and a low polydispersity index. The incorporation of AmB was high and depended on the volume fraction of the disperse phase. These MEs did not reduce the viability of J774.A1 macrophage-like cells for concentrations up to 25 μg/mL of AmB. Therefore, O/W MEs based on propylene glycol esters of caprylic acid may be considered as suitable delivery systems for AmB
Esta tese teve como objetivo o desenvolvimento de novos sistemas de libera??o para duas mol?culas distintas. Na primeira parte, micropart?culas ? base de xilana e Eudragit? S-100 foram produzidas para encapsular ?cido 5-aminosalic?lico visando ? libera??o c?lonespec?fica. A xilana foi extra?da de sabugos de milho e caracterizada quanto ?s suas propriedades f?sico-qu?micas, reol?gicas e toxicol?gicas. Em seguida, dois m?todos de microencapsula??o foram utilizados: reticula??o interfacial polim?rica e secagem por aspers?o. Os sistemas produzidos foram caracterizados quanto ? morfologia, tamanho m?dio e distribui??o, estabilidade t?rmica, cristalinidade, taxa de encapsula??o e libera??o do f?rmaco in vitro. Foram obtidas micropart?culas com adequadas caracter?sticas f?sicas e rendimentos satisfat?rios atrav?s dos dois m?todos, embora os sistemas aspergidos tenham apresentado maior estabilidade t?rmica e sejam considerados mais interessantes devido a sua maior estabilidade t?rmica e aus?ncia de agentes t?xicos. No entanto, ajustes precisam ser feitos para melhorar a encapsula??o e libera??o do f?rmaco. Na segunda parte, microemuls?es do tipo ?leo em ?gua (MEs O/A) com base em triglicer?deos de cadeia m?dia (MCT) foram produzidas visando ao carreamento de anfotericina B (AmB) e aumento da sua solubilidade. Foram obtidas MEs O/A sem e com AmB com got?culas em torno de 80 e 120 nm, respectivamente, e ?ndices de polidispers?o de 0,25 e 0,31, respectivamente. A taxa de incorpora??o da AmB foi alta e dependente do volume da fase dispersa. A viabilidade celular n?o foi afetada at? 25 μg/mL da AmB. Portanto, MEs O/A a partir de MCT podem ser promissores sistemas de libera??o para AmB
Huang, Tzu-Hsuan. "Fusion of anti-HER2/neu with inflammatory cytokines IFN-a and TNF-a results in molecules that elicit an anti-tumor response or potentiate wound healing." Diss., Restricted to subscribing institutions, 2006. http://proquest.umi.com/pqdweb?did=1276406491&sid=11&Fmt=2&clientId=1564&RQT=309&VName=PQD.
Full textGnansounou, Senankpon Martial. "Etude des activités anti-inflammatoire, antioxydante et screening par chromatographie gazeuse couplée à la spectrométrie de masse d’extraits éthanoliques de trois fabacées du Bénin : isolement de molécules bioactives." Thesis, Aix-Marseille, 2019. http://www.theses.fr/2019AIXM0603.
Full textIn a context of infectious diseases resurgence, our study focused on therapeutic potential of Dialium guineense, Parkia biglobosa and Tamarindus indica in order to search for bioactive molecules that can counter antibiotic resistance or its corollaries. The state of the art of on bioactive molecules from the three plants has shown that many families of compounds are identified in different aerial organs. However, the link with biological activities remains unclear. Next, we evaluated some biological activities of ethanolic or hydroethanolic extracts of leaves, fruits and bark. With good cell viability levels, extracts of D. guineense (bark) as well as those of P. biglobosa (leaves) and T. indica (bark) have anti-inflammatory activity ratios of 458.2; 161 and 174.6 respectively. These values are higher than that of dexamethasone used as positive control. The KRL test showed dose-dependent antiradical activity in the range of 0 to 20mg / L. In vitro, 1 g of each of the abovementioned extracts has an antioxidant capacity respectively equivalent to 1585 ; 2092 ; 5071 and 2246 mg of Trolox. The extracts were then analyzed by GC-MS revealing for the first time the presence of lupeol and sitosterol in the bark of D. guineense. Finally, the nutritional study of the three fruits reveals, through the high levels of nutrients (80% sugar for D. guineense), their possible contribution to fight malnutrition in Benin and the need of their conservation. Keywords : Infectious diseases, antimicrobial resistance, anti-inflammatory, antioxidant, bioactive molecules
D'ORAZIO, GIUSEPPE. "Glycoderivatives: drug candidates and molecular tools." Doctoral thesis, Università degli Studi di Milano-Bicocca, 2013. http://hdl.handle.net/10281/41154.
Full textPujo, Julien. "Caractérisation de molécules lipidiques produites par les bactéries probiotiques Escherichia coli Nissle 1917 : rôle dans l’homéostasie intestinale." Thesis, Toulouse 3, 2018. http://www.theses.fr/2018TOU30199.
Full textNumerous studies have highlighted the importance of intestinal microbiota in the physiology and physiopathology of the host. Bacteria, the most represented microorganisms of the microbiota, contribute to the maintenance of intestinal homeostasis by regulating several essential functions ranging from the protection of the intestinal barrier to the development of the immune system. Impairment in the composition and diversity of this microbiota have been observed in pathologies of digestive tract such as irritable bowel syndrome and inflammatory bowel disease. In order to restore intestinal homeostasis, therapies using probiotic bacteria were used. Among probiotic bacteria tested, Escherichia coli Nissle 1917 (E. coli Nissle 1917) has been used for its anti-diarrheal, analgesic and anti-inflammatory properties. Nevertheless, the mechanisms of action involved in these therapeutic effects remain unknown. In order to study them, we used two approaches in mass spectrometry to analyse bacterial lipids. A first untargeted approach, allowed us to highlight the production of lipopeptides including C12AsnGABAOH composed by a fatty acid of 12 carbons, an asparagine and GABA (gamma amino butyric acid), the main inhibitory neurotransmitter of the nervous system. This lipopeptide was produced by enzymes encoded by genes of a cluster call the pks island. In contrast to GABA alone, C12AsnGABAOH crosses the intestinal epithelial barrier (IEB) in vitro and in vivo. The addition of the aminolipid by the bacteria confer to the GABA the ability to reach sensory nerve endings. This lipopeptide decreased neuronal activation induced by activation of nociceptors in sensory neuron primary cultures via the GABAB receptor. In vivo, it inhibited visceral hypersensitivity induced by activation of nociceptors in mice. In a second study, we carried out a mass spectrometry targeted approaches looking for hydroxylated long chain fatty acids (LCFA) in different strains of E. coli. C18-3OH a LCFA of 18 carbons with a hydroxylation on its third position was produced in higher amounts by E. coli Nissle 1917 independently of the pks island. The C18-3OH was not able to cross the IEB and accumulated in cells in vitro, in tissues ex vivo and in colon in vivo. In tissues, C18-3OH modulated the expression of genes regulated by PPAR-γ receptor. Finally, in a DSS-induced colitis in mice, C18-3OH decreased paracellular permeability and inflammatory parameters. These thesis works allowed us to demonstrate for the first time that E. coli Nissle 1917 could signal to host cells by secreting lipopeptides and LCFAs. Two of them C12AsnGABAOH and C18-3OH were bioactive molecules. C12AsnGABAOH inhibited visceral hypersensitivity and C18-3OH reduced the inflammatory status of intestinal epithelial cells. These lipid compounds could be involved in the probiotic effects exerted by E. coli Nissle 1917 and represent therapeutic agents in the treatment of visceral pain and intestinal inflammation
Simi, Anastasia. "Molecular basis for the anti-inflammatory properties of chlomethiazole /." Stockholm, 2003. http://diss.kib.ki.se/2003/91-7349-621-9/.
Full textGURAU, FELICIA. "Anti-inflammatory effects of natural compounds: focus on miRNA modulation." Doctoral thesis, Università Politecnica delle Marche, 2020. http://hdl.handle.net/11566/274459.
Full textA challenging and promising new branch of aging-related research fields is the identification of natural compounds able to modulate senescence-associated secretory phenotype (SASP). SASP is the phenotype that characterize senescent cells (SCs) and can contribute to fuel the chronic pro-inflammatory systemic status associated with aging and with the development of the most common age-related diseases (ARDs). The aim of this study was the evaluation of the anti-SASP activity of Curcuma (CUR), resveratrol (RSV) and β-caryophyllene (BCP), alone and in combination (MIX), in two human cellular models involved in promoting inflammatory responses, such as the monocytic cell line, THP-1 and the endothelial primary cell line, HUVECs. Replicative and doxorubicin-induced senescent HUVECs (RS- and IS-HUVECs) were treated with the single natural compounds or with the mix of these substances. Notably, the mix was able to reduce more efficiently and significantly IL-1β and IL-6 expression levels, as well as to induce a significant down-regulation of miR-21 and miR-146a expression, and a significant up-regulation of miR-126 in both RS- and IS-HUVECs compared to single compounds. Moreover, the mix significantly contribute to restore the level of SIRT1 and p16ink4a protein in both RS- and IS-HUVECs. In LPS-stimulated THP-1 cells the mix was able to reduce the expression of IL-1β, IL-6, TNF-α and miR-146a compared to the non-treated cells. Our results showed a synergic effect of CUR, RSV and BCP in restrain SASP in HUVECs and the inflammatory response in THP1cells.
Clarke, Christopher Jeremy Paul. "Molecular mechanisms of the anti-inflammatory cytokines interleukin-4 and interleukin-10." Thesis, Imperial College London, 1997. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.285172.
Full textManabe, Yuki. "Studies on anti-inflammatory effects and underlying molecular mechanisms of marine carotenoids." Kyoto University, 2020. http://hdl.handle.net/2433/252997.
Full text0048
新制・論文博士
博士(農学)
乙第13346号
論農博第2889号
新制||農||1080(附属図書館)
学位論文||R2||N5253(農学部図書室)
京都大学大学院農学研究科応用生物科学専攻
(主査)教授 菅原 達也, 教授 佐藤 健司, 教授 澤山 茂樹
学位規則第4条第2項該当
England, Ross N. "Cellular Mechanisms of the Anti-Inflammatory Effects of Interleukin-19." Diss., Temple University Libraries, 2015. http://cdm16002.contentdm.oclc.org/cdm/ref/collection/p245801coll10/id/216875.
Full textPh.D.
BACKGROUND: Atherosclerotic vascular disease is a significant medical and socioeconomic problem and contributes to mortality in multiple diseases including myocardial infarction (MI), stroke, renal failure, and peripheral vascular disease. Atherosclerosis, as well as other vascular diseases including post-intervention restenosis and allograft vasculopathy, is known to be driven by chronic inflammation and, consequently, pro- and anti-inflammatory cell signaling molecules have been an important target of cardiovascular research. Interleukin (IL)-19 is a recently discovered member of the IL-10 family of anti-inflammatory cytokines. IL-19 is expressed in injured vascular cells, including vascular smooth muscle cells (VSMCs) and endothelial cells (ECs), where it exerts an anti-inflammatory effect. In VSMCs, IL-19 signaling results in inhibition of proliferation, migration, spreading, production of reactive oxygen species (ROSs), and expression of pro-inflammatory genes. In ECs, IL-19 signaling is pro-angiogenic and results in increased EC proliferation, migration, and spreading. AIMS and HYPOTHESIS: The goal of the present study was to explore the hypothesis that IL-19 mediates anti-inflammatory effects on vascular cells by inhibiting the expression of pro-inflammatory genes, such intercellular adhesion molecule (ICAM)-1, vascular cell adhesion molecule (VCAM)-1, IL-1β, IL-8, and monocyte chemotactic protein (MCP)-1, through modulation of the mRNA stability factor HuR by post- transcriptional (e.g., microRNA) and post-translational (e.g., serine phosphorylation) mechanisms. METHODS and RESULTS: We found that IL-19 can significantly inhibit tumor necrosis factor (TNF)-α-driven ICAM-1 and VCAM-1 mRNA and protein abundance in cultured human coronary artery ECs (p < 0.01). IL-19 treatment of ECs, but not monocytes, significantly inhibited monocyte adhesion to cultured EC monolayers (p < 0.01). In wild-type mice, systemic administration of IL-19 significantly reduced TNF-α-induced leukocyte rolling and adhesion as quantitated by intravital microscopy (p < 0.05). IL-19 failed to inhibit TNF-α-induced nuclear factor (NF)-κB activation in ECs. IL-19 inhibited nuclear-to-cytoplasmic translocation of HuR and significantly reduced mRNA stability of ICAM-1 and VCAM-1 (p < 0.01 ). IL-19 significantly inhibited serine-phosphorylation of HuR, which is required for its translocation, and significantly increased expression of the putative HuR regulator microRNA (miR)-133 in VSMCs. CONCLUSIONS: These data are the first to report that IL-19 can reduce leukocyte-EC interactions, and to propose reduction in HuR-mediated mRNA stability of ICAM-1 and VCAM-1 as a mechanism. We conclude that expression of IL-19 by ECs and VSMCs may represent an auto-regulatory mechanism to promote resolution of the vascular response to inflammation. These results suggest that IL-19 is anti-inflammatory in vascular cells and, therefore, may be of therapeutic value in atherosclerotic vascular disease.
Temple University--Theses
Bournazou, Irini. "Lactoferrin : an anti-inflammatory molecule released by apoptotic cells to inhibit granulocyte migration." Thesis, University of Edinburgh, 2010. http://hdl.handle.net/1842/9889.
Full textAl-Adlaan, Asaad A. "A NOVEL ANTI-INFLAMMATORY ROLE OF OSTEOACTIVIN/GPNMB INPOST-TRAUMATIC OSTEOARTHRITIS." Kent State University / OhioLINK, 2017. http://rave.ohiolink.edu/etdc/view?acc_num=kent15114587826723.
Full textHerman, Allison. "RNA-binding proteins mediate anti-inflammatory regulation of vascular disease." Diss., Temple University Libraries, 2019. http://cdm16002.contentdm.oclc.org/cdm/ref/collection/p245801coll10/id/554883.
Full textPh.D.
This work identifies the Fragile X-related protein (FXR1) as a reciprocal regulator of HuR target transcripts in vascular smooth muscle cells (VSMC). FXR1 was identified as an HuR interacting protein by liquid chromatography-tandem mass spectrometry (LC-MS/MS). The-HuR-FXR1 interaction is abrogated in RNase-treated extracts, indicating that their association is tethered by mRNAs. FXR1 expression is induced in diseased, but not normal arteries. SiRNA knock down of FXR1 increases abundance and stability of inflammatory mRNAs, while overexpression of FXR1 reduces their abundance and stability. RNA-EMSA and RIP demonstrate that FXR1 directly interacts with an ARE and a previously uncharacterized element in the 3’UTR of TNFa. FXR1 expression is increased in VSMC challenged with the anti-inflammatory cytokine IL-19, and FXR1 is required for IL-19 reduction of HuR. This suggests FXR1 is an anti-inflammation responsive, HuR counter-regulatory protein that reduces abundance of pro-inflammatory transcripts. Additionally, we observed significantly increased poly-A-Binding protein (PABP) expression localizing to discrete punctate structures in both vascular smooth muscle (VSMC) and endothelial cells (EC) of the aortic arch of Ldlr-/- mice, as compared to WT controls. EIF2α phosphorylation, requisite for SG formation, was also induced by clotrimazole and oxLDL in these cells. Interestingly, VSMCs pre-treated with anti-inflammatory cytokine IL-19 followed by clotrimazole significantly reduced the formation of SGs and eIF2a phosphorylation, suggesting a relationship between inflammation and SG formation in vascular cells. Reduction of SG component G3BP1 by siRNA knockdown significantly reduced stress granule formation and inflammatory gene abundance in hVSMC. Microtubule inhibitors reduced SG formation in hVSMC. These results support the hypothesis that SG formation in atherosclerosis is driven by inflammation, SG may mediate the cellular response to inflammation, and that anti-inflammatory treatment may lessen atherosclerosis progression and plaque formation by reduction of SGs.
Temple University--Theses
Sciara, Aubrey N. "Characterization of Pro-inflammatory and Anti-inflammatory Microglia in the Anterior Cingulate Cortex in Autism Spectrum Disorder." Digital Commons @ East Tennessee State University, 2016. https://dc.etsu.edu/etd/3109.
Full textChakrabarti, Arindam. "PKR DEPENDENT UPREGULATION OF IMMEDIATE EARLY GENES AND ANTI-INFLAMMATORY CYTOKINE IL-10." Kent State University / OhioLINK, 2007. http://rave.ohiolink.edu/etdc/view?acc_num=kent1176136341.
Full textChennamaneni, Snigdha. "FROM NON-STEROIDAL ANTI-INFLAMMATORY DRUG (NSIAD) INDOMETHACIN TO ANTI-CANCER AGENTS: DESIGN, SYNTHESIS, BIOLOGICAL EVALUATION AND MECHANISM INVESTIGATION." Cleveland State University / OhioLINK, 2014. http://rave.ohiolink.edu/etdc/view?acc_num=csu1421084668.
Full textDiaz-Cruz, Edgar S. "Interrelationships between aromatase and cyclooxygenase-2 and their role in the autocrine and paracrine mechanisms in breast cancer." Connect to resource, 2005. http://rave.ohiolink.edu/etdc/view?acc%5Fnum=osu1117117648.
Full textGatbonton-Schwager, Tonibelle N. "Biological and Chemical Analysis of Small Molecule Activators of Anti-inflammatory and Antioxidant Nrf2-Keap1 Signaling." Case Western Reserve University School of Graduate Studies / OhioLINK, 2014. http://rave.ohiolink.edu/etdc/view?acc_num=case1390560628.
Full textCristante, Enrico. "Impact of peripheral inflammation in the brain : new roles for the anti-inflammatory molecule Annexin A1." Thesis, Imperial College London, 2013. http://hdl.handle.net/10044/1/14415.
Full textSingh, Raminder [Verfasser], Rainer [Akademischer Betreuer] Haas, and Ulrich [Akademischer Betreuer] Rüther. "Molecular mechanisms of the anti-leukemic properties of Non-steroidal Anti Inflammatory Drugs / Raminder Singh. Gutachter: Ulrich Rüther. Betreuer: Rainer Haas." Düsseldorf : Universitäts- und Landesbibliothek der Heinrich-Heine-Universität Düsseldorf, 2011. http://d-nb.info/1017354839/34.
Full textNaidoo, Vinasan. "Diclofenac in Gyps vultures : a molecular mechanism of toxicity." Thesis, University of Pretoria, 2008. http://hdl.handle.net/2263/26027.
Full textThesis (PhD (Paraclinical Sciences))--University of Pretoria, 2007.
Paraclinical Sciences
unrestricted
Acosta, Sandra Antonieta. "Multivariate Anti-inflammatory Approaches to Rescue Neurogenesis and Cognitive function in Aged Animals." Scholar Commons, 2011. http://scholarcommons.usf.edu/etd/3712.
Full textNicholas, Courtney. "The Anti-Inflammatory Mechanisms of the Flavonoid Apigenin In Vitro and In Vivo." The Ohio State University, 2009. http://rave.ohiolink.edu/etdc/view?acc_num=osu1259783472.
Full textLabzin, Larisa [Verfasser]. "Investigating the molecular mechanism of the anti-inflammatory effects of High Density Lipoprotein in macrophages / Larisa Labzin." Bonn : Universitäts- und Landesbibliothek Bonn, 2015. http://d-nb.info/1077289634/34.
Full textBorges, Alexandre [UNESP]. "Estudos de modelagem molecular de lignanas em complexos com ciclooxigenases-1 e 2." Universidade Estadual Paulista (UNESP), 2016. http://hdl.handle.net/11449/140137.
Full textApproved for entry into archive by Ana Paula Grisoto (grisotoana@reitoria.unesp.br) on 2016-06-29T17:41:12Z (GMT) No. of bitstreams: 1 borges_a_dr_ilha.pdf: 4325586 bytes, checksum: 2f6ab56677aea7746bd28dad4b24ea23 (MD5)
Made available in DSpace on 2016-06-29T17:41:12Z (GMT). No. of bitstreams: 1 borges_a_dr_ilha.pdf: 4325586 bytes, checksum: 2f6ab56677aea7746bd28dad4b24ea23 (MD5) Previous issue date: 2016-05-11
Os inibidores seletivos da ciclooxigenase-2 (COX-2), como o rofecoxibe (2) e o celecoxibe (1), formam uma importante classe de medicamentos anti-inflamatórios desenvolvidos a partir da descoberta das duas isoformas das ciclooxigenases (COX-1 e COX-2) na década de 1979. A isoforma 1 esta relacionada com a citoproteção gástrica, agregação plaquetária e função renal e a isoforma 2 relacionada a processos inflamatórios. Estes inibidores seletivos apesar de não apresentarem os efeitos colaterais (ulceras e gastrites) dos anti-inflamatórios não esteroidais (AINEs) clássicos por inibirem apenas a COX-2, apresentam grave risco cardiovascular, o que motivou à retirada do rofecoxibe do mercado. Porém, por ser um eficiente inibidor seletivo da COX-2 a estrutura do rofecoxibe tornou-se referência no estudo de novas substâncias capazes de inibir seletivamente a COX-2. Dentre as ferramentas utilizadas na busca destas novas estruturas está a modelagem molecular através de programas como o GOLD 5.1, que foi utilizado neste trabalho. O uso do GOLD 5.1 possibilitou o estudo do comportamento das estruturas avaliadas em ligação com as ciclooxigenases. O objetivo foi obtenção de estruturas com comportamento semelhante ao rofecoxibe (em relação às COXs) como potenciais candidatos ao desenvolvimento de novos inibidores seletivos para a COX-2. O estudo foi realizado com 480 estruturas modeladas a partir de lignanas naturais como a hinoquinina, cubebina, deoxipodofilotoxina e podofilotoxina, que apresentam atividade anti-inflamatória in vivo ou in vitro, além de semelhanças estruturais com o rofecoxibe. A deoxipodofilotoxina por apresentar seletividade para a COX-2 em ensaio in vitro também foi utilizada como estrutura de referência além do rofecoxibe. Os resultados observados a partir da simulação molecular permitiram concluir que embora tanto o rofecoxibe como a deoxipodofilotoxina (3) inibam seletivamente a COX-2 in vitro, o fazem de modo diferente. Em relação a COX-2 as duas estruturas ocupam a mesma região do sítio ativo, mas o rofecoxibe apresenta interações mais fortes com o bolso hidrofílico desta isoforma (condição necessária para a inibição seletiva para os coxibes). Já para a COX-1 enquanto o rofecoxibe ocupa a porção superior do canal hidrofóbico (sítio ativo) como os demais AINEs, a deoxipodofilotoxina ocupa uma região vizinha. Pelos resultados obtidos é possível sugerir que tanto a maior flexibilidade das estruturas como a presença do anel lactônico, são importantes para um comportamento análogo ao rofecoxibe ou à deoxipodofilotoxina. Com relação à interação com o bolso hidrofílico da COX-2, os resultados sugerem que a presença de grupos aceptores de prótons menos volumosos nas posições C3 e C4, C3’ e C4’ ou C4 levam a resultados melhores que grupos aceptores de maior volume. A presença de grupos doadores de prótons apesar de permitirem forte interação com o bolso hidrofílico da COX-2 leva a resultados globais insatisfatórios, pois formam interações fortes com o resíduo Arg120 do sítio ativo da COX-1, interação considerada importante para a inibição não seletiva. Resultado semelhante à deoxipodofilotoxina foi observado apenas para a estrutura 17. As estruturas 37, 188, 266, 267, 348 e a hinoquinina (4) apresentam resultados semelhantes ao rofecoxibe, para as duas isoformas. Deste modo permite-se sugerir a partir dos resultados obtidos neste estudo que a hinoquinina (4) e as estruturas 17, 37, 188, 266, 267 e 348 apresentam-se como possíveis protótipos de fármacos que atuem como inibidores seletivos para a COX-2.
The selective inhibitors of the cyclooxygenase-2 (COX-2) as rofecoxib (2) and celecoxib (1), form an important class of anti-inflammatory drugs developed from the discovery of two isoforms of cyclooxygenases (COX-1 and COX-2) in the late 1979. Isoform 1 is related to the gastric cytoprotection, platelet and renal function and isoform 2 related to inflammatory processes. These selective inhibitors although they did not side effects (ulcers and gastritis) of the classic NSAIDs to inhibit only COX-2, have severe cardiovascular risk, which led to the withdrawal of rofecoxib from the market. However, to be an effective selective COX-2 to rofecoxib structure has a reference in the study of new substances capable of selectively inhibiting COX-2. Among the tools used in the search of these new structures is by molecular modeling program such as GOLD 5.1, which was used in this work. Using GOLD 5.1 made it possible to study the behavior of structures evaluated in binding with the cyclooxygenases. With the objective of obtaining structures with similar behavior to rofecoxib (regarding behavior with COX) as potential candidates for the development of new selective inhibitors for COX-2. The study was conducted with 480 structures modeled from natural lignans as hinokinin, cubebin, deoxypodophyllotoxin and podophyllotoxin, which have anti-inflammatory activity in vivo or in vitro as well as structural similarities with rofecoxib. The deoxypodophyllotoxin for presenting selectivity for COX-2 in the in vitro assay was also used as a reference structure beyond rofecoxib. The results observed from the molecular simulation showed that although both rofecoxib (2) as deoxypodophyllotoxin (3) selectively inhibit COX-2 in vitro, they do differently. In relation to COX-2 the two structures occupy the same region of the active site, but rofecoxib has stronger interactions with the hydrophilic pocket of this isoform (a necessary condition for the selective inhibition for coxibs). As for the COX-1 while rofecoxib occupies the upper portion of the hydrophobic channel (active site) like other NSAIDs, the deoxypodophyllotoxin occupies a neighboring region. From the results it is possible to suggest that the greater flexibility of the structures such as the presence of the lactone ring, are important for a similar behavior to rofecoxib or deoxipodofilotoxina. With respect to the interaction with the hydrophilic pocket COX-2, the results suggest that the presence of acceptors groups less bulky protons in posítions C3 and C4, C3 ' and C4' and C4 lead to better results than acceptors groups of larger volume. The presence of proton donors groups despite allowing strong interaction with the hydrophilic pocket COX-2 lead to poor overall results, since they form strong interactions with Arg120 residue of COX-1 active site, considered important interaction for inhibiting non-selective. Results similar to deoxipodofilotoxina was only observed for structure 17. Structures 37, 188, 266, 267, 348 and hinokinin (4) show results similar to rofecoxib for the two isoforSA. Thus it allows suggest from the results obtained in this study hinokinin (4) and structures 17, 37, 188, 266, 267 and 348 are shown as possible prototype drugs that act as selective inhibitors for COX-2.
Borges, Alexandre. "Estudos de modelagem molecular de lignanas em complexos com ciclooxigenases-1 e 2 /." Ilha Solteira, 2016. http://hdl.handle.net/11449/140137.
Full textResumo: Os inibidores seletivos da ciclooxigenase-2 (COX-2), como o rofecoxibe (2) e o celecoxibe (1), formam uma importante classe de medicamentos anti-inflamatórios desenvolvidos a partir da descoberta das duas isoformas das ciclooxigenases (COX-1 e COX-2) na década de 1979. A isoforma 1 esta relacionada com a citoproteção gástrica, agregação plaquetária e função renal e a isoforma 2 relacionada a processos inflamatórios. Estes inibidores seletivos apesar de não apresentarem os efeitos colaterais (ulceras e gastrites) dos anti-inflamatórios não esteroidais (AINEs) clássicos por inibirem apenas a COX-2, apresentam grave risco cardiovascular, o que motivou à retirada do rofecoxibe do mercado. Porém, por ser um eficiente inibidor seletivo da COX-2 a estrutura do rofecoxibe tornou-se referência no estudo de novas substâncias capazes de inibir seletivamente a COX-2. Dentre as ferramentas utilizadas na busca destas novas estruturas está a modelagem molecular através de programas como o GOLD 5.1, que foi utilizado neste trabalho. O uso do GOLD 5.1 possibilitou o estudo do comportamento das estruturas avaliadas em ligação com as ciclooxigenases. O objetivo foi obtenção de estruturas com comportamento semelhante ao rofecoxibe (em relação às COXs) como potenciais candidatos ao desenvolvimento de novos inibidores seletivos para a COX-2. O estudo foi realizado com 480 estruturas modeladas a partir de lignanas naturais como a hinoquinina, cubebina, deoxipodofilotoxina e podofilotoxina, que apre... (Resumo completo, clicar acesso eletrônico abaixo)
Abstract: The selective inhibitors of the cyclooxygenase-2 (COX-2) as rofecoxib (2) and celecoxib (1), form an important class of anti-inflammatory drugs developed from the discovery of two isoforms of cyclooxygenases (COX-1 and COX-2) in the late 1979. Isoform 1 is related to the gastric cytoprotection, platelet and renal function and isoform 2 related to inflammatory processes. These selective inhibitors although they did not side effects (ulcers and gastritis) of the classic NSAIDs to inhibit only COX-2, have severe cardiovascular risk, which led to the withdrawal of rofecoxib from the market. However, to be an effective selective COX-2 to rofecoxib structure has a reference in the study of new substances capable of selectively inhibiting COX-2. Among the tools used in the search of these new structures is by molecular modeling program such as GOLD 5.1, which was used in this work. Using GOLD 5.1 made it possible to study the behavior of structures evaluated in binding with the cyclooxygenases. With the objective of obtaining structures with similar behavior to rofecoxib (regarding behavior with COX) as potential candidates for the development of new selective inhibitors for COX-2. The study was conducted with 480 structures modeled from natural lignans as hinokinin, cubebin, deoxypodophyllotoxin and podophyllotoxin, which have anti-inflammatory activity in vivo or in vitro as well as structural similarities with rofecoxib. The deoxypodophyllotoxin for presenting selectivity for COX... (Complete abstract click electronic access below)
Doutor
Lu, Pinyi. "Computational modeling-based discovery of novel classes of anti-inflammatory drugs that target lanthionine synthetase C-like protein 2." Diss., Virginia Tech, 2015. http://hdl.handle.net/10919/64370.
Full textPh. D.
Abrantes, Vanessa Erika Ferreira. "A modelagem molecular da proteína pha-like de Acacia Farnesiana revela mecanismo anti-inflamatório." Universidade Federal da Paraíba, 2013. http://tede.biblioteca.ufpb.br:8080/handle/tede/3655.
Full textCoordenação de Aperfeiçoamento de Pessoal de Nível Superior - CAPES
Lectins are proteins or glycoproteins of non-immune origin that have at least one non-catalytic site which binds reversibly to carbohydrates and glycoconjugates, which makes them ideal models for studies of cell-cell interactions and cell-virus, being good models for the design of new drugs. Some carbohydrate-binding proteins resembling the lectins but with some structural and functional differences, that exclude of this group. The Fabaceae Acacia farnesiana has in its seeds an agglutinin chitin-binding (AFAL), classified as PHA-like1. Its standard chromatographic revealed time-dependent oligomerization. This dynamic behavior complicates the protein crystallization and determining of the three dimensional structure. To better understand the structure-function relationship, this study aimed to examine AFAL anti-inflammatory activity through structural comparison with legume lectins. For both, it was the molecular modeling and docking with a glycan and carrageenan. AFAL model is folded as a β sandwich, which differs from the template used (Pisum sativum lectin) in loop regions, number of β-sheets and carbohydrate site. The docking showed that the protein binds to the carrageenan and glycan at different sites, which can be explained by absence of the sixth β-sheet (frontal β-sheets) and two β-sheets in posterior region. The A. farnesiana agglutinin can inhibit carrageenan induced inflammation due binding it, preventing its entrance into the cell and triggers the inflammatory process reactions.
Lectinas são proteínas e/ou glicoproteínas de origem não imune que possuem, no mínimo, um sítio não-catalítico que se liga de forma reversível a carboidratos e glicoconjugados, o que as tornam modelos ideais de estudos de interações célula-célula, célula-vírus, sendo bons modelos para o desenho de novos fármacos. Algumas proteínas possuem capacidade de se ligar a carboidratos, assemelhando-se às lectinas, porém com algumas diferenças estruturais e funcionais, que as excluem desse grupo. A Fabaceae Acacia farnesiana possui em suas sementes uma aglutinina ligante de quitina (AFAL), classificada como PHA-like1. Seu padrão cromatográfico revelou oligomerização tempo-dependente. Esse comportamento dinâmico dificulta a cristalização dessa proteína, bem como determinação da estrutura tridimensional. Visando compreender melhor a relação estrutura-função, este trabalho teve por objetivo analisar a atividade anti-inflamatória de AFAL através de comparação estrutural com lectinas de leguminosas. Para tanto, fez-se a modelagem e docking molecular com um glicano e a carragenina. A AFAL apresentou um modelo dobrado como um sanduiche de folhas β, que difere do molde utilizado (lectina de Pisum sativum) em regiões de loops, no número de folhas β e no sítio de ligação à carboidratos. O docking revelou que a proteína se liga à carragenina e ao glicano em sítios diferentes, o que pode ser explicado pela ausência de uma sexta folha β frontal e de duas folhas β na região posterior. A aglutinina de A. farnesiana pode inibir a inflamação causada por carragenina, por se ligar a ela, impedindo sua entrada na célula e o desencadeamento de reações típicas do processo inflamatório.
Shamsudin, Khan Yasmin. "Non-Steroidal Anti-Inflammatory Drugs in Cyclooxygenases 1 and 2 : Binding modes and mechanisms from computational methods and free energy calculations." Doctoral thesis, Uppsala universitet, Beräkningsbiologi och bioinformatik, 2017. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-328478.
Full textDu, Bin. "Effect of molecular weight and structure on anti-inflammatory properties of polysaccharide from submerged mycelial fermentation of schizophyllum commune /Du Bin." HKBU Institutional Repository, 2016. https://repository.hkbu.edu.hk/etd_oa/363.
Full textAlanazi, Samyah T. "The effects of small molecule analogues of the anti-inflammatory parasitic worm product ES-62 on the metabolome of mouse bone marrow-derived macrophages." Thesis, University of Strathclyde, 2018. http://digitool.lib.strath.ac.uk:80/R/?func=dbin-jump-full&object_id=30466.
Full textLarge, Martin [Verfasser], Franz [Akademischer Betreuer] Rödel, Markus [Akademischer Betreuer] Löbrich, and Bodo [Akademischer Betreuer] Laube. "Cellular and molecular aspects of the anti-inflammatory effects of low-dose radiation therapy / Martin Large. Betreuer: Franz Rödel ; Markus Löbrich ; Bodo Laube." Darmstadt : Universitäts- und Landesbibliothek Darmstadt, 2015. http://d-nb.info/1112268855/34.
Full textJacobo-Herrera, Nadia Judith. "Anti-inflammatory properties and bioactive natural products from Witheringia solanacea, Withania frutescens (Solanaceae) and Valeriana officinalis (Valerianaceae) using NF-kappa as a molecular target." Thesis, University College London (University of London), 2005. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.420313.
Full textSantos, Bruna Celeida Silva. "Síntese e modelagem molecular de análogos do metil chavicol e seus potenciais farmacológicos." Universidade Federal de Juiz de Fora (UFJF), 2017. https://repositorio.ufjf.br/jspui/handle/ufjf/6070.
Full textApproved for entry into archive by Adriana Oliveira (adriana.oliveira@ufjf.edu.br) on 2018-01-23T11:54:04Z (GMT) No. of bitstreams: 1 brunaceleidasilvasantos.pdf: 5993103 bytes, checksum: 7eedadf4d8bccdd543fe319f2058cbd4 (MD5)
Made available in DSpace on 2018-01-23T11:54:04Z (GMT). No. of bitstreams: 1 brunaceleidasilvasantos.pdf: 5993103 bytes, checksum: 7eedadf4d8bccdd543fe319f2058cbd4 (MD5) Previous issue date: 2017-02-24
Metil chavicol é um fenilpropanoide encontrado em óleos essenciais e suas atividades antimicrobiana, anti-inflamatória, anestésica local e inseticida têm sido destacadas. O objetivo deste estudo foi sintetizar e avaliar o perfil de interação molecular do metil chavicol e análogos, assim como investigar as atividades antioxidante, antilipidêmica e anti-inflamatória tópica usando métodos in vivo, in vitro e in silico. A síntese dos análogos foi realizada por reações clássicas da química orgânica. A atividade antioxidante foi determinada pelos métodos DPPH e peroxidação lipídica, enquanto o efeito antilipidêmico foi testado contra a enzima lipase pancreática. O efeito anti-inflamatório tópico foi avaliado pelo método de edema de orelha usando óleo de Cróton, fenol e histamine como agentes irritantes. Análises histopatológicas e ensaios de mieloperoxidase (MPO), N-acetil-β-D-glicosaminidase (NAG), óxido nitrico, fator necrose tumoral (TNF-α), interleucina 6 (IL-6) e ciclooxigenase in vitro foram realizados. Os ligantes foram gerados pelo Programa Marvin Sketch e refinado por método PM7 presente no Programa MOPAC2012. As enzimas foram obtidas do Protein Data Bank sob os códigos 1EQG e 5IKT (COX-1 e -2), 1R35 (iNOS) e 1LPA (lipase pancreática). O reconhecimento molecular foi definido usando o programa Discovery Studio v 4.5 2016. 2-[(4-metoxifenil)metil] oxirano (2), 3-(4-metoxifenil)propan-1,2-diol (8), 2-metoxi-3-(4 metoxifenil)propan-1-ol (10), 1-metoxi-3-(4 metoxifenil)propan-2-ol (17) e 3-(4-metoxifenil)propanal (18) foram os análogos sintetizados. Metil chavicol reduziu significativamente (p < 0,001) a espessura e a massa do edema de orelha induzido por óleo de Cróton, fenol e histamina. Houve uma redução significativa de mieloperoxidase, N-acetil-β-D-glicosaminidase, óxido nítrico, fator necrose tumoral (TNF-α) e interleucina 6 (IL-6). Metil chavicol foi incapaz de inibir COX-1 e -2 em estudo in vitro e o docking molecular mostrou ausência de interação, incluindo os análogos 2, 8, 17 e 18. Além disso, os estudos in vitro e de docking molecular revelaram que o metil chavicol e seus análogos inibiram a enzima lipase pancreática. Os resultados obtidos sugerem que o metil chavicol e seus análogos são promissores agentes terapêuticos que podem ser utilizados em doenças associadas a processos inflamatórios, oxidativos e metabólicos.
Methyl chavicol is a phenylpropanoid found in essential oils and its antimicrobial, anti-inflammatory, local anesthetic and insecticide activities have been highlighted. The objective of this study was to synthesize and evaluate the molecular interaction profile of the methyl chavicol and analogues, as well as to investigate the antioxidant, antilipidemic and topical anti-inflammatory activities using in vivo, in vitro and in silico methods. Synthesis of the analogues was performed by classical reactions of organic chemistry. Antioxidant activity was determined by DPPH and lipid peroxidation methods, while the antilipidemic effect was essayed against to pancreatic lipase. Anti-inflammatory activity was evaluated using Croton oil-, phenol-, and histamine-induced ear edema models in mice. Histopathological analyzes and the myeloperoxidase (MPO), N-acetyl-β-D-glucosaminidase (NAG), nitric oxide, tumor necrosis tumor (TNF-α), interleukin 6 (IL-6) and cyclooxygenase assays were determined. The bindings were generated by the Marvin Sketch Program and refined by PM7 method present in the MOPAC2012 Program. Enzymes were obtained from protein database under 1EQG and 5IKT (COX-1 and -2), 1R35 (iNOS) and 1LPA (pancreatic lipase) codes. Molecular recognition was determined using the program Discovery Studio v 4.5 2016. 2 - [(4-methoxyphenyl) methyl] oxirane (2), 3-(4-methoxyphenyl) propane-1,2-diol (8), 2- Methoxy-3-(4-methoxyphenyl) propan-1-ol), 1-methoxy-3-(4-methoxyphenyl) propan-2-ol (17) and 3-(4-methoxyphenyl) propanal (18) were the synthesized analogues. Methyl chavicol significantly decreased the thickness and mass of ear edema induced by irritants (p < 0.001). A significant reduction on myeloperoxidase, N-acetyl-β-D-glucosaminidase, nitric oxide, tumor necrosis tumor (TNF-α) and interleukin 6 (IL-6) was revealed (p < 0.05, p < 0.01 or p < 0.001). Methyl chavicol was unable to inhibit COX-1 and-2 in in vitro test and the molecular docking showed no interaction, including the analogues 2, 8, 17 and 18. In addition, molecular docking showed an inhibitory effect of the methyl chavicol and its analogues on the pancreatic lipase. The results indicate that methyl chavicol and its analogues are promising therapeutic agents that can be used in diseases associated with inflammatory, oxidative and metabolic processes.
GOMES, Marcelo do Nascimento. "Planejamento, síntese e avaliação farmacológica de novos candidatos a protótipos de fármacos anti-inflamatórios." Universidade Federal de Goiás, 2009. http://repositorio.bc.ufg.br/tede/handle/tde/2136.
Full textIn the field of a research line that seeks the planning, the synthesis and the pharmacologycal evaluation of new candidates to prototypes of anti-inflammatory drugs, we will describe in this project the planning of derived new pyrazolics (LQFM 002-003), originally drawn starting from the nerolidilcatecol (24) and arylsulfonilpiperazines, (25) that present profile inhibition of the enzyme sPLA2. The compounds (E)-N-(3,7-dimethylocta-2,6-dienyl)-1,3-dimethtyl-1-H-pyrazol-5-amine (LQFM 002) and (E)-N-(3,7-dimethylocta-2,6-dienyl)-1,3-dimethyl-4-((4-methylpiperazin-1-il) methyl)-1H-pyrazol-5-amine (LQFM 003), were submitted to pharmacologycal rehearsals in vitro, seeking to evaluate the enzymatic inhibition activity of the sPLA2. For the prototype (LQFM 002) the inhibition halos were 14,43 ± 6,28%, 16,68 ± 2,45%, 23,61 ± 2,62%, 37,06 ± 3,25%, in the doses of 250, 500, 1000 and 2000 μg/mL respectively. For the compound (LQFM 003), the halos were 1,85 ± 1,38%, 9,29 ± 3,33%, 7,82 ± 3,32%, 13,21 ± 3,22%, respectively. Subsequently the rehearsal in vivo was accomplished to evaluate the profile of cellular migration. Being also analyzed the concentration of plasmatic protein by the methodology of the Evans of blue once the inflammatory process was induced. The compound (LQFM 002) presented inhibition on cellular migration of 50,46 ± 14,34% in the peritonit test, 68,7 ± 2,65% in the pleurisy test and reduction of 40,1 ± 6,40% of the plasmatics proteins for the method of coloration of the Evans of blue. The compound (LQFM 003) presented 25,89 ± 5,39% inhibition, in the doses of 50 mg/Kg, characterizing, significant anti-inflammatory profile for the prototype (LQFM 002). Parallel to the pharmacologycal synthetic work and, we carried out theoretical studies through the application of molecular dynamics. The parameters of the enzyme sPLA2 was more effective through the applications of the water box's, once the smaller state energy observed was of -175000kcal/mol. At the end of this project, we can conclude that the structural planning applied in the project was validated through the applications of the pharmacologycal rehearsals, once both molecules were recognized by the enzyme sPLA2 and they presented anti-inflammatory activity in the rehearsal of cellular migration. In addition, the applied synthetic methodology for obtaining of the prototypes pyrazolics (LQFM 002-003) studied was satisfatory.
No âmbito de uma linha de pesquisa que visa o planejamento, a síntese e a avaliação farmacológica de novos candidatos a protótipos de fármacos anti-inflamatórios, descreveremos neste trabalho o planejamento de novos derivados pirazólicos (LQFM 002-003), originalmente desenhados a partir do nerolidilcatecol (24) e arilsulfonilpiperazínicos (25), que apresentam perfil inibitório da enzima sPLA2. Os compostos (E)-N-(3,7-dimetilocta-2,6-dienil)-1,3-dimetil-1-H-pirazol-5-amina (LQFM 002) e (E)-N-(3,7-dimetilocta-2,6-dienil)-1,3-dimetil-4-((4-metilpiperazina-1-il) metil)-1H-pirazol-5-amina (LQFM 003), foram submetidos a ensaios farmacológicos in vitro, visando avaliar a atividade de inibição enzimática da sPLA2. Para o protótipo LQFM 002 os halos de inibição foram 14,43 ± 6,28%, 16,68 ± 2,45 %, 23,61 ± 2,62 %, 37,06 ± 3,25 %, nas doses de 250, 500, 1000 e 2000 μg/mL respectivamente. Para o composto LQFM 003, os halos foram 1,85 ± 1,38 %, 9,29 ± 3,33 %, 7,82 ± 3,32 %, 13,21 ± 3,22 %, respectivamente. Posteriormente foram realizados os ensaios in vivo o qual avalia o perfil de migração celular para cavidade peritoneal e pleural. Sendo também analisada a concentração de proteína plasmática pela metodologia do azul de Evans quando induzido o processo inflamatório. O composto LQFM 002 apresentou inibição sobre a migração celular de 50,46 ± 14,34 % no teste de peritonite, 68,7 ± 2,65 % no teste de pleurisia e redução de 40,1 ± 6,40 % das proteínas plasmáticas pelo método de coloração do azul de Evans. O composto LQFM 003 apresentou inibição de 25,89 ± 5,39%, nas doses de 50 mg/Kg, caracterizando, desta forma, perfil anti-inflamatório significativo para o protótipo (LQFM 002). Paralelamente ao trabalho sintético e farmacológico, foi realizado estudos teóricos através do emprego de dinâmica molecular. A parametrização da enzima sPLA2 foi mais efetiva através do emprego de caixa de água, uma vez que o estado de menor energia observado foi de -175000kcal/mol. Ao término deste trabalho, podemos concluir que o planejamento estrutural empregado no mesmo foi validado através dos ensaios farmacológicos empregados, uma vez que ambas as moléculas foram reconhecidas pela enzima sPLA2 e apresentaram atividade anti-inflamatória no ensaio de migração celular. Ademais, a metodologia sintética empregada se mostrou satisfatória para a obtenção dos protótipos pirazólicos (LQFM 002 - 003) estudados.
Silva, Daiany Priscilla Bueno da. "Atividade anti-inflamatória e antinociceptiva de 4-((1-fenil-1h-pirazol-4-il) metil) piperazina-1-carboxilato: um novo derivado piperazínico." Universidade Federal de Goiás, 2015. http://repositorio.bc.ufg.br/tede/handle/tede/5497.
Full textApproved for entry into archive by Luciana Ferreira (lucgeral@gmail.com) on 2016-04-20T13:32:30Z (GMT) No. of bitstreams: 2 Dissertação - Daiany Priscilla Bueno da Silva - 2015.pdf: 1122736 bytes, checksum: fc98524b1ad5d0e3a0cb2e1cc87bc933 (MD5) license_rdf: 23148 bytes, checksum: 9da0b6dfac957114c6a7714714b86306 (MD5)
Made available in DSpace on 2016-04-20T13:32:30Z (GMT). No. of bitstreams: 2 Dissertação - Daiany Priscilla Bueno da Silva - 2015.pdf: 1122736 bytes, checksum: fc98524b1ad5d0e3a0cb2e1cc87bc933 (MD5) license_rdf: 23148 bytes, checksum: 9da0b6dfac957114c6a7714714b86306 (MD5) Previous issue date: 2015-02-25
Conselho Nacional de Pesquisa e Desenvolvimento Científico e Tecnológico - CNPq
The piperazines derivatives are an important class of chemical compounds with a broad spectrum of biological activities such as anti-infectious activity, anti-carcinogenic, anti-nociceptive, anti-hypertensive, anxiolytic and vasorelaxant and are attractive candidates for development of new analgesics and anti-inflammatories drugs. The aim of this study was evaluate the effects of piperazine compound LQFM-008 (4-[(1-phenyl-1H-pyrazol-4-yl) methyl]1-piperazine carboxylic acid ethyl ester) in acute tests of nociception and inflammation and characterize that the mechanisms are involved in the antinociceptive effect. For this study were used male mice weighing between 25 and 35g. In the formalin test, the treatments with LQFM-008 at doses of 48 and 96 μmol/kg (p.o.) reduced the licking time at both neurogenic and inflammatory phases of this test. The anti-inflammatory activity was confirmed, since LQFM-008 at doses of 48 and 96 μmol/kg (p.o.) reduced the formation of paw edema induced by carrageenan at all hours of the test and LQFM-008 in pleurisy test at dose of 96 μmol/kg (p.o.) also reduced leukocyte migration and protein exudation. In the tail-flick and the hot plate tests, the treatment with LQFM-008 at doses of 48 and 96 μmol/kg (p.o.) increased the latency to thermal stimulus, suggesting the involvement of central mechanisms in the antinociceptive effect LQFM-008. The pre-treatment of animals with naloxone (7.5 μmol/kg s.c.) reversed the antinociceptive effect of LQFM-008 only in the first phase of the formalin test, however, the pre-treatment with NAN-190 (1.3 μmol/kg i.p.) and PCPA (500 μmol/kg i.p.) reversed the antinociceptive effect of LQFM-008 in both phases of the test. Thus, the piperazine derivative LQFM-008 exhibit antinociceptive and anti-inflammatory activities in acute test and the antinociceptive effect is resulting from a central action with involvement of opioid receptors and the serotonin pathway.
Os derivados piperazínicos constituem uma importante classe de compostos químicos com largo espectro de atividades biológicas, tais como atividade anti-infecciosa, anti-cancerígena, antinociceptiva, anti-hipertensiva, vasorrelaxante e ansiolítica, tornando-se candidatos atrativos para desenvolvimento de novos fármacos analgésicos e anti-inflamatórios. O objetivo do presente trabalho foi avaliar os efeitos do composto piperazínico LQFM-008 (4-((1-fenil-1H-pirazol-4-il) metil) piperazina-1-carboxilato) em testes agudos de nocicepção e inflamação, buscando caracterizar quais os mecanismos de ação estariam envolvidos no efeito antinociceptivo. Para este estudo foram utilizados camundongos machos, pesando entre 25 e 35g. No teste da formalina os tratamentos com LQFM-008 nas doses de 48 e 96 μmol/kg (v.o.) reduziram o tempo de reatividade à dor tanto na fase neurogênica quanto na fase inflamatória do teste. A atividade anti-inflamatória foi confirmada, uma vez que LQFM-008 nas doses de 48 e 96 μmol/kg (v.o.) reduziu a formação do edema de pata induzido por carragenina em todas as horas deste teste e no teste de pleurisia LQFM-008 na dose de 96 μmol/kg também reduziu a migração de leucócitos e a exsudação proteica. Nos testes de flexão de cauda e da placa quente, o tratamento com LQFM-008 48 e 96 μmol/kg (v.o.) aumentou a latência ao estímulo térmico, sugerindo o envolvimento de mecanismos centrais no efeito antinociceptivo de LQFM-008. O pré-tratamento dos animais com naloxona (7,5 μmol/kg s.c.) reverteu o efeito antinociceptivo de LQFM-008 apenas na primeira fase do teste da formalina, no entanto, os pré-tratamentos com NAN-190 (1,3 μmol/kg i.p.) e PCPA (500 μmol/kg i.p.) reverteram o efeito antinociceptivo de LQFM-008 em ambas as fases do teste. Assim o derivado piperazínico LQFM-008 apresenta atividade antinoceptiva e anti-inflamatória em testes agudos, sendo efeito antinociceptivo decorrente de uma ação central com envolvimento dos receptores opióides e da via serotoninérgica.
Pereira, M?rcia de Oliveira. "Avalia??o de efeitos biol?gicos de antiinflamat?rios derivados do ?cido propi?nico atrav?s de modelos experimentais em n?vel molecular e celular." Universidade Federal do Rio Grande do Norte, 2010. http://repositorio.ufrn.br:8080/jspui/handle/123456789/13319.
Full textConselho Nacional de Desenvolvimento Cient?fico e Tecnol?gico
Derivatives of propionic acid NSAIDs are irreversible inhibitors of cyclooxygenase enzyme widely used. The aim of this study was to evaluate, through different experimental models, biological effects of derivatives of propionic acid (fenoprofen, naproxen, ibuprofen and ketoprofen) in cellular and molecular level. The labeling of blood constituents with technetium-99m (99mTc) and morphological analysis of erythrocytes of blood of rats, as well as growth, survival of cultures of Escherichia coli (E. coli) and the assessment of bacterial plasmid electrophoretic profiles were models used for experimental evaluation of possible biological effects of antiinflammatory drugs. The results show that, in general, anti-inflammatory drugs evaluated were not able to alter the labeling of blood constituents with 99mTc, the morphology of red blood cells from blood of rats, as well as the growth of cultures of E. coli and the electrophoretic profile of plasmid DNA. However, naproxen appears to cytotoxic effect on bacterial cultures, plasmids and genotoxic effects in reducing the action of stannous chloride in cultures of E. coli. The use of experimental fast performance and low cost was important for assessment of biological effects, contributing to a better understanding of the properties of propionic acid derivatives studied. anti-inflammatory, blood constituents, technetium-99m, stannous chloride, Escherichia coli; DNA
Os derivados do acido propi?nico s?o antiinflamat?rios n?o esteroidais inibidores irrevers?veis da enzima cicloxigenase amplamente utilizados. O objetivo deste trabalho foi avaliar, atrav?s de diferentes modelos experimentais, efeitos biol?gicos de derivados do ?cido propi?nico (fenoprofeno, naproxeno, ibuprofeno e cetoprofeno) em n?vel celular e molecular. A marca??o de constituintes sangu?neos com tecn?cio 99m (99mTc) e a an?lise morfol?gica de hem?cias de sangue de ratos Wistar, bem como, o crescimento, sobreviv?ncia de culturas de Escherichia coli (E. coli) e a avalia??o do perfil eletrofor?tico plasm?dios bacterianos, foram modelos experimentais utilizados para avalia??o de poss?veis efeitos biol?gicos dos antiinflamat?rios. Os resultados obtidos demonstram que, de modo geral, os antiinflamat?rios avaliados n?o foram capazes de alterar a marca??o de constituintes sangu?neos com 99mTc, a morfologia de hem?cias de sangue de ratos Wistar, assim como, o crescimento de culturas de E. coli e o perfil eletrofor?tico de plasm?dios. Entretanto, o naproxeno parece apresentar efeito citot?xico em culturas bacterianas, efeito genot?xico em plasm?dios e diminui??o da a??o do cloreto estanoso em culturas de E. coli. A utiliza??o de modelos experimentais de r?pida realiza??o e baixo custo se mostrou importante para avalia??o de efeitos biol?gicos, contribuindo para uma melhor compreens?o das propriedades dos derivados do ?cido propi?nico estudados. Esse trabalho teve car?ter multidisciplinar e na vig?ncia dos aux?lios concedidos pela CAPES, FAPERJ e CNPq
Pokrzywa, Malgorzata. "A Drosophila Disease-Model for Transthyretin-associated Amyloidosis." Doctoral thesis, Umeå : Umeå University, 2008. http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-1677.
Full textKaraderi, Tugce. "Genetics of ankylosing spondylitis." Thesis, University of Oxford, 2012. http://ora.ox.ac.uk/objects/uuid:8c0e848a-e712-4603-b923-a96a2f1644ac.
Full textChen, Wen-Yi, and 陳文藝. "In silico selections for design of anti-inflammatory therapeutic molecules." Thesis, 2012. http://ndltd.ncl.edu.tw/handle/54215293572649529406.
Full text慈濟大學
微生物學免疫學暨生物化學碩士班
100
Background: Human CXCL8 plays important roles in inflammation by activation of neutrophils through hCXCR1 and hCXCR2 receptors. The role of hCXCR1 and hCXCR2 in the pathogenesis of inflammatory responses has encouraged the development of antagonists of these receptors. Due to the fact that hCXCR1 and hCXCR2 are membrane proteins, they are difficult to be purified for X-ray crystallography. Therefore, hCXCR1 and hCXCR2 structures have not yet existed in ProteinDataBank. In this study, we simulated the three-dimensional structure of CXCR1 using homology modeling. And this structure is used for molecular docking in order to design anti-inflammatory drugs. Methodology/Principal Findings: Using the Phyre2 which applies a profile-profile alignment algorithm for searching the ideal template, 1U19, a new high-resolution (2.2 A) structure, was found. We performed homology modeling to construct 100 structures of hCXCR1 using Discovery Studio v. 3.1 by superimposed and analyzed top 10 structures with minimized energy. The Root Mean Squarer Deviation (RMSD) of these 10 structures was less than 0.4 A. The CXCR1 model was obtained by averaging the top10 structures. Subsequently, the CXCL8 and CXCR1 were docked to simulate the specific binding sites. The results showed that there were three fragments which might be important for the ligand-receptor binding. All the forces between the receptor and the ligand were calculated with the ZRank. The selected peptides were then synthesized and tested for their functions on the THP-1cell using flow cytometry. Summary/Significance: Our simulation results demonstrated that there are a large number of attractions between the selected peptides and CXCR1, such us hydrogen bonds and van der Waals forces. As observed in flow cytometry study, selected peptides did indeed associate with the cells. However, it is still not certain if the selected peptides have the ability to compete with CXCL8 so far.
Lopes, Paloma Levy. "Development of anti-inflammatory starch-based dressings using tomato byproducts-derived molecules." Master's thesis, 2021. http://hdl.handle.net/10773/32833.
Full textMuitos dos curativos para feridas atualmente utilizados não são os ideais para um processo de cura total, rápido e eficaz devido à sua reduzida biocompatibilidade, oriunda da sua natureza sintética e da ausência de propriedades funcionais. Como alternativa têm sido desenvolvidos novos curativos de origem biológica com atividade antimicrobiana e/ou anti inflamatória. No entanto, os polímeros de origem natural até à data utilizados provêm de alimentos, atuando como competidores para a alimentação humana. As biomoléculas derivadas dos subprodutos da indústria agroalimentar podem ajudar a superar esta competição. Neste trabalho foi estudada a viabilidade da utilização de moléculas derivadas dos subprodutos de tomate para o desenvolvimento de pensos à base de amido com propriedades anti-inflamatórias. Para o efeito foi estudada a influência da concentração (1%, 5% e 10% m/m em relação à massa seca de amido) de extratos solúveis em água quente derivados to repiso de tomate, ricos em polissacarídeos (TE) e/ou compostos fenólicos (PE), nas propriedades cromáticas, mecânicas, físico-químicas e ativas (anti-inflamatórias e antimicrobianas) dos filmes à base de amido obtidos pelo método de evaporação do solvente. Num conceito de economia circular, o amido foi recuperado de lamas provenientes do processamento industrial de batata. Os extratos TE e PE apresentaram, respetivamente, 14,7% e 18,5% de proteína, 43,7% e 28,6% de polissacarídeos, 2,8% e 15,1% de compostos fenólicos e promissora atividade antioxidante (IC50 de 2,5 mg/mL e 0,8 mg/mL, respetivamente). Quando incorporados em formulações à base de amido, os extratos TE e PE permitiram desenvolver filmes transparentes com coloração amarelada e menor rigidez e resistência à tração do que os filmes controlo. TE originou filmes hidrofóbicos e flexíveis, enquanto PE diminuiu a hidrofobicidade e extensibilidade dos filmes. Quanto às propriedades ativas, ambos os filmes com TE e PE demostraram atividade anti-inflamatória quando na presença de um agente pró-inflamatório, observando-se, ao fim de 24 h, uma diminuição da inflamação de cerca de 48% e 100% para os filmes à base de amido com 10% de TE e PE, respetivamente. Com o intuito de desenvolver pensos à base de amido, neste trabalho também se otimizou a eletrofiação de soluções à base de amido. Após o ajuste do solvente, da concentração de amido e do tempo necessário para a sua dissolução foram obtidas fibras à base amido, porém em baixa quantidade para posterior aplicação no desenvolvimento de pensos. As biomoléculas existentes no repiso de tomate e o amido recuperado das lamas de lavagem de batata mostraram-se promissores para o desenvolvimento de curativos anti-inflamatórios de origem biológica, o que permitirá promover dispositivos médicos para cura de feridas mais biocompatíveis e funcionais dos que os materiais derivados de polímeros sintéticos inertes.
Mestrado em Biotecnologia
HSUEH, CHIH-CHI, and 薛志麒. "The Anti-inflammatory study of small molecules new dosage forms from Antrodia cinnamomea." Thesis, 2017. http://ndltd.ncl.edu.tw/handle/94477797268686351279.
Full text元培醫事科技大學
生物科技暨製藥技術系碩士班
105
The Antrodia cinnamomea are recognized as a folk medicine in Taiwan, detoxification effect with liver, however its mechanisms of detoxification until not clear. Therefore, the present experiment that we test the small molecule isolation of the Antrodia cinnamomea extract with new formulations of film-coated capsule, analysis its liver anti-inflammatory effect of the acute injury SD rats subjected to carbon tetrachloride (CCl4). The experimental results demonstrate that administration of carbon tetrachloride after injection, SD rats serum concentrations of nitric oxide (NO) and reactive oxygen species (ROS) are significantly increased on the CCl4 group but the NO and ROS concentration significantly reduced on the Antrodia cinnamomea group (P <0.05). We also find the small molecule isolation compound of the Antrodia cinnamomea extract from the liver tissues of the Antrodia cinnamomea group SD rats by HPLC method. The small molecule isolation of the Antrodia cinnamomea with new formulations could decrease the liver damage of SD rat subjected to CCl4. Taken together, these results indicate that the mechanism of new formulations the Antrodia cinnamomea extract involves the antioxidant metabolism and detoxification capacity through scavenging of NO and ROS in CCl4-stressed SD rat.
Shepherd, Catherine. "Exploring low molecular weight molecules produced by hookworms (Ancylostoma caninum) and their use as anti-inflammatory agents." Thesis, 2017. https://researchonline.jcu.edu.au/56036/1/JCU_56036-shepherd-2017-thesis.pdf.
Full textMencel, Malwina. "Potential Roles for the Neurotrophic Molecules Agrin and Neuregulin in Regulating Aspects of the Inflammatory Response." Thesis, 2014. http://hdl.handle.net/10012/8490.
Full textJoone, Gisela Käthe. "Die immuunmodulerende eienskappe van oksihumaat : 'n in vivo en in vitro ondersoek (Afrikaans)." Thesis, 2004. http://hdl.handle.net/2263/26739.
Full textTaofiq, Oludemi. "The contribution of phenolic acids to the anti-inflammatory activity of mushrooms: screening in phenolic extracts, individual parent molecules and synthesized glucuronated and methylated derivatives." Master's thesis, 2015. http://hdl.handle.net/10198/12103.
Full textIn the present study, the ethanolic extracts of fourteen wild edible mushrooms were investigated for their anti-inflammatory potential in LPS (Lipopolysaccharide) activated RAW 264.7 macrophages. Furthermore the extracts were chemically characterized in terms of phenolic acids and related compounds. The identified parent molecules (p-hydroxybenzoic, p-coumaric and cinnamic acids) and their synthesised glucuronated and methylated derivatives obtained by chemical synthesis were evaluated for the same bioactivity, in order to establish a structure-activity relationship, and to understand the contribution of the compounds to the activity of the extracts. The extract Pleurotus ostreatus, Macrolepiota procera, Boletus impolitus and Agaricus bisporus revealed the strongest anti-inflammatory potential, presenting also the highest concentration in cinnamic acid, which was also the individual compound with the highest anti-inflammatory activity. The derivatives of p-coumaric acid revealed the strongest properties, especially the compound CoA-M1, that exhibited a very similar activity to the one showed by dexamethasone used as anti-inflammatory standard; by contrast, the p-hydroxybenzoic derivatives revealed the lowest inhibition of NO production. All in all, whereas the conjugation reactions change the chemical structure of phenolic acids and may increase or decrease their activity, the glucuronated and methylated derivatives of the studied compounds are still displaying anti-inflammatory activity.